Evoco repowers zombie NEI

Evoco’s restructuring of an ailing private equity portfolio (backed by secondaries firm Headway Capital) illustrates one way that the industry can deal with its many dysfunctional funds.

1 September 2013•5 mins read
Feature image
LinkedInXEmail

SECONDARIES INVESTOR

Register to unlock this content

  • Daily global secondaries market news and intelligence
  • Curated insights to keep you ahead of GP-led and LP-led secondaries
  • Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
  • Access to proprietary research and reports
  • Selected fund performance and investor activity data
LinkedInXEmail